PULMATRIX, INC. Earnings Per Share (Basic)
PULMATRIX, INC. (PULM) reported Earnings Per Share (Basic) of -$0.29 per share for the 3-month period ending 2026-06-30, per its S-4/A filed 2026-09-17.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-09-17
- PULMATRIX, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.29.
- PULMATRIX, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.32.
- PULMATRIX, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.24.
- PULMATRIX, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.42.
- PULMATRIX, INC. earnings per share, basic for fiscal 2023 was -$3.87.
- PULMATRIX, INC. earnings per share, basic for fiscal 2022 was -$5.46.
- PULMATRIX, INC. earnings per share, basic for fiscal 2021 was -$8.63.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$0.29 S-4/A · filed 2026-09-17 | -$0.61 S-4/A · filed 2026-09-17 | |||
| 2026-03-31 | -$0.32 S-4/A · filed 2026-08-03 | ||||
| 2025-12-31 | -$1.41 S-4/A · filed 2026-09-17 | ||||
| 2025-09-30 | -$0.24 10-Q · filed 2025-10-16 | -$1.16 10-Q · filed 2025-10-16 | |||
| 2025-06-30 | -$0.42 S-4/A · filed 2026-09-17 | -$0.92 S-4/A · filed 2026-09-17 | |||
| 2025-03-31 | -$0.50 S-4/A · filed 2026-08-03 | $0.50 10-Q · filed 2025-05-15 | |||
| 2024-12-31 | -$2.62 S-4/A · filed 2026-09-17 | ||||
| 2024-09-30 | -$0.71 10-Q · filed 2025-10-16 | -$2.07 10-Q · filed 2025-10-16 | |||
| 2024-06-30 | -$1.59 10-Q · filed 2025-08-06 | -$1.37 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | $0.23 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | -$3.87 10-K · filed 2025-03-21 | ||||
| 2023-09-30 | -$1.03 10-Q · filed 2024-11-08 | -$3.30 10-Q · filed 2024-11-08 | |||
| 2023-06-30 | -$1.04 10-Q · filed 2024-08-13 | -$2.26 10-Q · filed 2024-08-13 | |||
| 2023-03-31 | -$1.22 10-Q · filed 2024-05-10 | ||||
| 2022-12-31 | -$5.46 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$1.45 10-Q · filed 2023-11-09 | -$4.32 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | -$1.36 10-Q · filed 2023-08-10 | -$2.87 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | -$1.51 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | -$8.63 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$2.91 10-Q · filed 2022-11-10 | -$6.08 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | -$1.37 10-Q · filed 2022-08-10 | -$3.10 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |